Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Novakovic VA"'
Autor:
Lukić Radiša Ž., Novaković Vaso Đ., Rabrenović Dragoman R., Lukić Slaviša Ž., Petrović Dejan A.
Publikováno v:
Tehnika, Vol 71, Iss 3, Pp 389-398 (2016)
Geological study of 'Delici and Peljave - Tobut' coal deposit, located in north-eastern part of the Republic of Srpska (B&H), has given a new insight into geological structure of coal-bearing series and quality of coal. Coal-bearing series was formed
Externí odkaz:
https://doaj.org/article/8ecd82e463b74e038f3378aeb355e21b
Autor:
Wu X; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, 150001, China.; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education Harbin, Harbin, China.; School of Basic Medical Sciences, Harbin Medical University, Harbin, China., Novakovic VA; Department of Research, Harvard Medical School, VA Boston Healthcare System, Boston, MA, USA., Shi J; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, 150001, China. jialan_shi@dfci.harvard.edu.; Department of Research, Harvard Medical School, VA Boston Healthcare System, Boston, MA, USA. jialan_shi@dfci.harvard.edu.; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA. jialan_shi@dfci.harvard.edu.
Publikováno v:
Angiogenesis [Angiogenesis] 2024 May; Vol. 27 (2), pp. 125-127. Date of Electronic Publication: 2024 Mar 26.
Autor:
Wu X; Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China., Xiang M; Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China., Jing H; Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China., Wang C; Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China., Novakovic VA; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA., Shi J; Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China. jialan_shi@dfci.harvard.edu.; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA. jialan_shi@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, MA, Boston, USA. jialan_shi@dfci.harvard.edu.
Publikováno v:
Angiogenesis [Angiogenesis] 2024 Feb; Vol. 27 (1), pp. 5-22. Date of Electronic Publication: 2023 Apr 27.
Autor:
Jing H; Department of Hematology, The First Hospital, Harbin Medical University, Harbin 150001, China., Wu X; Department of Hematology, The First Hospital, Harbin Medical University, Harbin 150001, China., Xiang M; Department of Hematology, The First Hospital, Harbin Medical University, Harbin 150001, China., Wang C; Department of Hematology, The First Hospital, Harbin Medical University, Harbin 150001, China., Novakovic VA; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA 02132, USA., Shi J; Department of Hematology, The First Hospital, Harbin Medical University, Harbin 150001, China.; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA 02132, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02132, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 24; Vol. 15 (7). Date of Electronic Publication: 2023 Mar 24.
Autor:
Wu X; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China., Xiang M; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China., Jing H; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China., Liu L; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China., Wang C; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China., Novakovic VA; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts, USA., Shi J; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, People's Republic of China; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jialan_shi@dfci.harvard.edu.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Mar; Vol. 29 (3), pp. 284-287. Date of Electronic Publication: 2022 Nov 19.
Autor:
Xiang M; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Wu X; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Jing H; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Novakovic VA; Department of Research, Veterans Affairs Boston Healthcare System and Harvard Medical School, Boston, MA, United States., Shi J; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.; Department of Research, Veterans Affairs Boston Healthcare System and Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Feb 07; Vol. 10, pp. 1062491. Date of Electronic Publication: 2023 Feb 07 (Print Publication: 2023).
Autor:
Carman CV; Harvard School of Public Health, Boston, MA.; Department of Medicine, VA Boston Healthcare System, Boston, MA., Nikova DN; Department of Medicine, VA Boston Healthcare System, Boston, MA., Sakurai Y; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Shi J; Department of Medicine, VA Boston Healthcare System, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Novakovic VA; Department of Medicine, VA Boston Healthcare System, Boston, MA., Rasmussen JT; Protein Chemistry Laboratory, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark., Lam WA; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Gilbert GE; Department of Medicine, VA Boston Healthcare System, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jan 10; Vol. 7 (1), pp. 60-72.
Autor:
Jing H; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, China., Wu X; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, China., Xiang M; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, China., Liu L; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, China., Novakovic VA; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States., Shi J; Department of Hematology, The First Hospital, Harbin Medical University, Harbin, China.; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Nov 16; Vol. 13, pp. 992384. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).
Autor:
Xiang M; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Wu X; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Jing H; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Liu L; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Wang C; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Wang Y; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China., Novakovic VA; Department of Research, Veterans Affairs (VA) Boston Healthcare System, Harvard Medical School, Boston, MA, United States., Shi J; Department of Hematology, the First Hospital, Harbin Medical University, Harbin, China.; Department of Research, Veterans Affairs (VA) Boston Healthcare System, Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Sep 28; Vol. 13, pp. 955654. Date of Electronic Publication: 2022 Sep 28 (Print Publication: 2022).
Autor:
Liu L; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Jing H; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Wu X; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Xiang M; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Novakovic VA; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States., Wang S; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China., Shi J; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Aug 05; Vol. 9, pp. 957006. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).